About 77,500 results
Open links in new tab
Patritumab Deruxtecan BLA Submission Receives Complete …
Patritumab Deruxtecan Demonstrated Statistically Significant ...
Patritumab Deruxtecan Demonstrated Statistically Significant
Patritumab Deruxtecan Granted Priority Review in the U.S. for
Patritumab Deruxtecan Active in HER3-Expressing ... - ASCO Daily News
FDA Grants Breakthrough Therapy Status to Patritumab Deruxtecan …
Patritumab Deruxtecan Produces Durable Responses in Patients …
Daiichi Sankyo and MSD’s ADC improves progression-free survival …
- Some results have been removed